Creative Medical Technology Holdings, Inc.
- Last sale
- Nov 12, 2026 · -0.13%
- Market cap
- $4.70M
- 7.6M shares
- Filings
- 412
Q3 2026−45.5% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
—
—
—Q3 2026N/M FY25 yoy
Q3 2026+21.3% FY25 yoy
- $4.70M
- —
- 1567.9×
- 0.7×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $6,000 | reported | |
| FY 2024 | 2024-12-31 | $11,000 | reported | |
| FY 2023 | 2023-12-31 | $9,000 | reported | |
| FY 2022 | 2022-12-31 | $88,600 | reported | |
| FY 2021 | 2021-12-31 | $87,754 | reported | |
| FY 2020 | 2020-12-31 | $164,500 | reported | |
| FY 2019 | 2019-12-31 | $165,500 | reported | |
| FY 2018 | 2018-12-31 | $124,400 | reported | |
| FY 2017 | 2017-12-31 | $4,800 | reported | |
| FY 2016 | 2016-12-31 | $0 | reported | |
| FY 2015 | 2015-12-31 | $0 | reported | |
| FY 2014 | 2014-12-31 | $0 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $10.00K | $10.00K | — | 3.70M sh | +43.0% | — |
| FY2024 | — | $174.96K | $174.96K | — | 2.59M sh | +90.6% | — |
| FY2023 | — | $270.95K | $270.95K | — | 1.36M sh | −90.4% | — |
| FY2022 | — | $0.00 | $0.00 | — | 14.08M sh | +116.1% | — |
Segments
Products
LineFY2025ShareChange
ImmCelz Patent$20.00K64%±0.0%
IND$10.00K32%±0.0%
EDI Patent$1.04K3.4%−89.6%
Total$31.04K
Biological products, except diagnostic substances
Creative Medical Technology Holdings, Inc. is the 89th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
IMAImageneBio, Inc.$800.0K77.1%5,668.6%$45.0MCRDFCardiff Oncology, Inc.$593.0K13.2%7,732.0%$56.8MATYRaTYR PHARMA INC$190.0K19.1%39,009.5%$16.3MVIVSVivoSim Labs, INC.$131.0K9.0%10,567.2%$2.8MAIMAIM ImmunoTech Inc.$88.0K48.2%15,861.4%$5.8MINMBInmune Bio, Inc.$50.0K257.1%91,866.0%$32.2MENTXEntera Bio Ltd.$42.0K76.8%27,235.7%$559.9MSNTISenti Biosciences Holdings, Inc.$22.0K—279,263.6%$12.5M
CELZCreative Medical Technology Holdings, Inc. (this company)$6.0K45.5%99,916.8%$4.7M
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Creative Medical Technology Holdings, Inc. · CIK 1187953 · Engraved from SEC EDGAR